Ordering
Available Variants50 mg
CHA.45900-50mg
Price
€211.20
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
50 mg | CHA.45900-50mg | €211.20 |
≥98% (TLC), powder, adenosine receptor agonist
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C12H16N6O4 |
|---|---|
| CAS Number | 35920-39-9 |
| Molecular Weight | 308.29 |
| UNSPSC Code | 12352200 |
| PubChem Substance ID | 24277684 |
| NACRES | NA.77 |
| MDL number | MFCD00069195 |
| Form | powder |
| Quality level | 200 |
Safety Information Handling visibility
| pictograms |
GHS06
 GHS06
|
|---|---|
| signalword | Danger |
| hcodes | H300 |
| pcodes | P264 - P301 + P310 |
| Hazard Classifications | Acute Tox. 2 Oral |
| Storage Class | 6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges |
Technical Overview & Applications Use-case context
NECA, also known as 5-N-ethylcarboxamidoadenosine, is a potent agonist of adenosine receptors, specifically targeting the A2 and A3 subtypes. With a chemical formula of C12H15N5O3 and a molecular weight of 279.28 g/mol, NECA is a synthetic analog of adenosine, exhibiting increased stability and resistance to enzymatic degradation. Its CAS number is 35920-39-9, and it is commonly used in research settings to study the physiological and pharmacological effects of adenosine receptor activation. NECA has been shown to modulate various biological processes, including vasodilation, platelet aggregation, and neurotransmitter release, making it a valuable tool for investigating the therapeutic potential of adenosine receptor-targeting compounds in the treatment of cardiovascular, neurological, and inflammatory disorders. Its high affinity for adenosine receptors enables NECA to elicit pronounced biological responses at relatively low concentrations.
